- Home
- OCS vs STEW Comparison
OCS vs STEW Comparison
Compare OCS & STEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OCS | STEW |
|---|---|---|
| Founded | 2003 | N/A |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.7B |
| IPO Year | 2022 | 1996 |
Fundamental Metrics
Financial Performance| Metric | OCS | STEW |
|---|---|---|
| Price | $12.71 | $18.89 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $42.00 | N/A |
| AVG Volume (30 Days) | ★ 280.4K | 76.0K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $466.06 | N/A |
| Revenue Next Year | $479.73 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.52 | $16.55 |
| 52 Week High | $34.48 | $19.05 |
Technical Indicators
Market Signals| Indicator | OCS | STEW |
|---|---|---|
| Relative Strength Index (RSI) | 52.83 | 69.82 |
| Support Level | $10.63 | $17.62 |
| Resistance Level | $14.35 | N/A |
| Average True Range (ATR) | 0.59 | 0.22 |
| MACD | 0.32 | 0.03 |
| Stochastic Oscillator | 79.22 | 84.09 |
Price Performance
Historical ComparisonAbout OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.
About STEW SRH Total Return Fund Inc.
SRH Total Return Fund, Inc. is a non-diversified closed-end management investment company. The company's investment objective is to seek total returns. Its fund utilizes a bottom-up, value-driven investment process to identify securities of good quality businesses trading below estimated intrinsic value. The Funds are available as an actively-managed closed-end fund, an actively managed ETF and a passively-managed ETF.